When GSK-3β activation is enhanced by Aβ, GSK-3β accelerates Tau-Ser396 phosphorylation, which is responsible for PHTs and NHFs, thereby causing AD [18] Aβ and Tau serve as an initiator and an executor of AD, respectively [19]. Here, MAPT is linked to Alzheimer disease.